Magnetic resonance imaging and67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: A prospective pilot study

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 4, Issue 3-4, 1996, Pages 213-224

  Bendini, Matteo ^a,b   Zuiani, Chiara ^a   Bazzocchi, Massimo ^a   Dalpiaz, Giorgina ^a   Zaja, Francesco ^a   Englaro, Emanuela ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

67Ga scan; Bulky mediastinal disease; Computed tomography; Lymphoma; Magnetic resonance imaging

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HODGKIN DISEASE; HUMAN; LYMPHOMA; MALE; MEDIASTINUM TUMOR; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; GALLIUM RADIOISOTOPES; HODGKIN DISEASE; HUMANS; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MAGNETIC RESONANCE IMAGING; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030430098     PISSN: 13528661     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01772009     Document Type: Article

References (29)

1. Jochelson M, Mauch P, Balikian J, et al. (1985) The significance of the residual mediastinal mass in treated Hodgkin's disease. J Clin Oncol 3: 634-640.
2. Radford JA, Cowan RA, Flanagan M, et al. (1988) The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol 6: 940-946.
3. Higgins CB, Hricak H, Helms CA (1990) Role of MRI in the staging of thoracic lymphoma. In Higgins, ed. Magnetic Resonance Imaging of the Body. pp. 484-489. New York: Raven Press.
4. Lewis E, Bernardino ME, Salvator PG, et al. (1982) Post therapy CT detected mass in lymphoma patients. It is a viable tissue? J Comput Assist Tomogr 6: 792-796.
5. Nyman R, Rehn SM, Glimelius BLG, et al. (1989) Residual mediastinal masses in Hodgkin's disease: prediction of size with MR imaging. Radiology 170: 435-440.
6. Skillings JR, Bramwell V, Nicholson RL, et al. (1991) A prospective study of magnetic resonance imaging in lymphoma staging. Cancer 67: 1838-1843.
7. Nyman R, Rehn SM, Glimelius BLG, et al. (1987) Magnetic resonance imaging for assessment of treatment effects in mediastinal Hodgkin's disease. Acta Radiol 28: 145-151.
8. Glazer SH, Lee JKT, Levit RG (1985) Radiation fibriosis: differentiation from recurrent tumor by MR imaging. Radiology 156: 721-726.
9. Front D, Ben-Haim S, Israel O, et al. (1992) Lymphoma: predictive value of Ga-67 scintigraphy after treatment. Radiology 182: 359-363.
10. Drossman SR, Schiff RG, Kronfeld GD, et al. (1990) Lymphoma of the mediastinum and neck: evaluation with Ga-67 imaging and CT correlation. Radiology 174: 171-175.
11. Bekerman C, Hoffer PB, Bitran JD (1985) The role of Ga-67 in the clinical evaluation of cancer. Sem Nucl Med 14: 296-303.
12. Israel O, Front D, Lam M (1988) 67-Gallium imaging in monitoring lymphoma response to treatment. Cancer 61: 2439-2443.
13. Kaplan WD, Jochelson M, Herman T (1988) 67-Gallium imaging: a predictor of residual tumor viability in patients with diffuse large cell lymphoma (abstract). J Clin Oncol 6: 230.
14. Gasparini MD, Balzarini L, Castellani MR, et al. (1993) Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma. Cancer 72: 577-582.
15. Andersen KC, Leonard RCF, Canellos GP, et al. (1983) High dose gallium imaging in lymphoma. Am J Med 75: 327-331.
16. Heshiki A, Schatz S, Mc Kusick, et al. (1974) Gallium-67 scanning in patients with pulmonary sarcoidis. Am J Roentgenol 122: 744-749.
17. Rahmouni A, Zerhouni EA (1990) Role of MRI in the management of thoracic lymphoma. In: Zerhouni EA, ed. CT and MRI of the Thorax, pp. 23-35. New York: Churchill Livingstone.
18. Rahmouni A, Tempany C, Jones R, et al. (1993) Lymphoma: monitoring tumor size and signal intensity with MR imaging. Radiology 188: 445-451.
19. Foss Abrahamsen A, Lien HH, Aas M, et al. (1994) Magnetic resonance imaging and 67-gallium scan in mediastinal malignant lymphoma: a prospective pilot study. Ann Oncol 5: 433-436.
20. Castellino RA (1986) Hodgkin disease: practical concepts for the diagnostic radiologist. Radiology 159: 305-310.
21. Castellino RA (1991) Non-Hodgkin lymphomas: practical concepts for the diagnostic radiologist. Radiology 178: 315-321.
22. Brice P, Rain JD, Frija J, et al. (1993) Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and 67-gallium scan. Nouv Rev Fr Hematol 35: 457-461.
23. Rehn SM, Nyman RS, Glimelius BLG, et al. (1990) Non-Hodgkin lymphoma: predicting prognostic grade with MR imaging. Radiology 176: 249-253.
24. Front D, Bar-Shalom R, Epelbaum R, et al. (1993) Early detection of lymphoma recurrence with 67-gallium scintigraphy. J Nucl Med 34: 2101-2104.
25. Hoane BR, Shields AF, Porter BA, et al. (1994) Comparison of initial lymphoma staging using computed tomography (CT) and magnetic resonance imaging (MRI). Am J Hematol 47: 100-105.
26. North LB, Fuller LM, Sullivan Halley JA, et al. (1987) Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval. Radiology 164: 599-602.
27. Olson EM, Colleen JB, King MA (1995) Fast SE MRI of the chest: parameter optimization and comparison with conventional SE imaging. Comput Assist Tomogr 19: 167-175.
28. Smith RC, Constable RT, Reinhold C (1994) Fast spin echo STIR imaging. J Comput Assist Tomogr 18: 209-213.
29. Canini R, Battista G, Monetti N, et al. (1995) Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses. Radiol Med 90: 448-456.